Predicting the curative effects of TPD chemotherapy for HER2-positive breast cancer using tumor-infiltrating lymphocytes

被引：0
|
作者：
Kashiwagi, Shinichiro [1 ]
Goto, Wataru [1 ]
Asano, Yuka [1 ]
Takashima, Tsutomu [1 ]
Onoda, Naoyoshi [1 ]
Hirakawa, Kosei [1 ]
Ohira, Masaichi [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O1 - 8 - 2
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer
    Heppner, B. Ingold
    Untch, M.
    Denkert, C.
    Pfitzner, B. M.
    Lederer, B.
    Schmidt, W.
    Eidtmann, H.
    Fasching, P.
    Tesch, H.
    Solbach, C.
    Rezai, M.
    Zahm, D. -M.
    Holms, F.
    Glados, M.
    Krabisch, P.
    Heck, E.
    Ober, A.
    Lorenz, P.
    Diebold, K.
    Habeck, J.
    Loibl, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 5 - 5
  • [2] Tumor-Infiltrating Lymphocytes and Immune Response in HER2-Positive Breast Cancer
    Luque, Melani
    Sanz-Alvarez, Marta
    Morales-Gallego, Miriam
    Madoz-Gurpide, Juan
    Zazo, Sandra
    Dominguez, Carolina
    Cazorla, Alicia
    Izarzugaza, Yann
    Arranz, Juan Luis
    Cristobal, Ion
    Rojo, Federico
    CANCERS, 2022, 14 (24)
  • [3] Prognostic Implication of Tumor-Infiltrating Lymphocytes in Patients With HER2-Positive Breast Cancer
    Yoshida, E. J.
    Li, Q.
    Chung, A.
    Knudsen, B.
    Burnison, M.
    Mirhadi, A. J.
    Zumsteg, Z. S.
    Giuliano, A. E.
    Amersi, F. F.
    Shiao, S. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S44 - S45
  • [4] Investigating the role of tumor-infiltrating lymphocytes in advanced HER2-positive breast cancer
    Luen, Stephen J.
    Loi, Sherene
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (01)
  • [5] Prognostic value of tumor-infiltrating lymphocytes in small HER2-positive breast cancer
    Criscitiello, C.
    Bagnardi, V.
    Pruneri, G.
    Vingiani, A.
    Esposito, A.
    Rotmensz, N.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade
    Liefaard, M. C.
    van der Voort, A.
    van Seijen, M.
    Thijssen, B.
    Sanders, J.
    Vonk, S.
    Mittempergher, L.
    Bhaskaran, R.
    de Munck, L.
    van Leeuwen-Stok, A. E.
    Salgado, R.
    Horlings, H. M.
    Lips, E. H.
    Sonke, G. S.
    NPJ BREAST CANCER, 2024, 10 (01)
  • [7] Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer
    Abe, Norie
    Matsumoto, Hirofumi
    Takamatsu, Reika
    Tamaki, Kentaro
    Takigami, Naoko
    Uehara, Kano
    Kamada, Yoshihiko
    Tamaki, Nobumitsu
    Motonari, Tokiwa
    Unesoko, Mikiko
    Nakada, Norihiro
    Zaha, Hisamitsu
    Yoshimi, Naoki
    VIRCHOWS ARCHIV, 2020, 476 (05) : 701 - 709
  • [8] Quantitative digital image analysis of tumor-infiltrating lymphocytes in HER2-positive breast cancer
    Norie Abe
    Hirofumi Matsumoto
    Reika Takamatsu
    Kentaro Tamaki
    Naoko Takigami
    Kano Uehara
    Yoshihiko Kamada
    Nobumitsu Tamaki
    Tokiwa Motonari
    Mikiko Unesoko
    Norihiro Nakada
    Hisamitsu Zaha
    Naoki Yoshimi
    Virchows Archiv, 2020, 476 : 701 - 709
  • [9] HER2-Positive Breast Cancer: Association of MRI and Clinicopathologic Features With Tumor-Infiltrating Lymphocytes
    Lee, Hyo-Jae
    Lee, Jong Eun
    Jeong, Won Gi
    Ki, So Yeon
    Park, Min Ho
    Lee, Ji Shin
    Nah, Yoo Kyeong
    Lim, Hyo Soon
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 218 (02) : 258 - 269
  • [10] Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
    Kurozumi, Sasagu
    Inoue, Kenichi
    Matsumoto, Hiroshi
    Fujii, Takaaki
    Horiguchi, Jun
    Oyama, Tetsunari
    Kurosumi, Masafumi
    Shirabe, Ken
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345